As medical imaging of the eye tissue becomes more advanced, including three dimensional options, important details can at times be lost in hazy areas that lack sharpness.

Individuals taking an oral acne medication may be at an added risk of developing pink eye. New findings suggest isotretinoin ( Accutane ) could double your risk as compared to patients who don't take it.

Patients suffering from dry eye syndrome may find relief from an unexpected source. New research suggests that caffeine may help the eye produce tears, potentially relieving the uncomfortable dryness.

Researchers have found that a key part of the immune system is linked to developing age-related macular degeneration (AMD), one of the most common causes of blindness.

Passing a state driving test may not necessarily mean driving at night is safe. Those who suffer from cataracts or blurred vision appear to have difficulty recognizing pedestrians at night -- even after passing an eye exam.

For patients with an uncommon, painful eye condition that can gradually lead to blindness, the ability to identify and treat it early could be key to management of the disorder.

Patients with a persistent form of diabetic macular edema, which causes swelling of the retina, appear to do better with a prescribed drug over laser therapy, the long-preferred treatment for the eye condition.

A common oral antibiotic used to treat bone and joint infections, severe ear infections, urinary infections and bronchitis may slightly increase the risk of developing a serious eye condition called retinal detachment.

Scientists have found a method for creating laboratory-built retina structures from human blood. The synthetic retinas could be used to study and test drugs for degenerative eye disease, including retinitis pigmentosa , which causes blindness.

An eye exam can do far more than screen for potential vision problems. It also can give doctors a view into the body's vascular system, and it may even be able to pinpoint patients more likely to suffer cognitive decline.